Oldest pages

Jump to navigation Jump to search

Showing below up to 50 results in range #501 to #550.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

  1. Disposal facility‏‎ (22:02, 24 February 2021)
  2. Dose modifying factor‏‎ (22:03, 24 February 2021)
  3. Exposure pathway‏‎ (22:05, 24 February 2021)
  4. Radiological controlled area‏‎ (22:07, 24 February 2021)
  5. Life Span Study‏‎ (22:10, 24 February 2021)
  6. Detriment‏‎ (19:17, 25 February 2021)
  7. Baseline disease rates‏‎ (19:29, 25 February 2021)
  8. Biomarker‏‎ (19:31, 25 February 2021)
  9. Case–control study‏‎ (19:33, 25 February 2021)
  10. Deterministic effect‏‎ (19:38, 25 February 2021)
  11. Dose and dose-rate effectiveness factor‏‎ (15:54, 26 February 2021)
  12. Dose-threshold hypothesis‏‎ (15:56, 26 February 2021)
  13. Tissue reaction‏‎ (16:00, 26 February 2021)
  14. Doubling dose‏‎ (17:10, 26 February 2021)
  15. Epigenetic effects‏‎ (17:13, 26 February 2021)
  16. Excess absolute risk‏‎ (17:16, 26 February 2021)
  17. Excess relative risk‏‎ (17:25, 26 February 2021)
  18. Homologous recombination‏‎ (17:26, 26 February 2021)
  19. Incidence‏‎ (17:28, 26 February 2021)
  20. Induced genomic instability‏‎ (17:30, 26 February 2021)
  21. Late normal tissue responses‏‎ (17:31, 26 February 2021)
  22. LD 50/30‏‎ (17:33, 26 February 2021)
  23. Lifetime risk estimates‏‎ (17:42, 26 February 2021)
  24. Linear dose response‏‎ (17:43, 26 February 2021)
  25. Linear-quadratic dose response model‏‎ (17:48, 26 February 2021)
  26. Stochastic effect‏‎ (17:58, 26 February 2021)
  27. Nominal risk coefficient‏‎ (19:29, 26 February 2021)
  28. Non-homologous end joining‏‎ (19:30, 26 February 2021)
  29. Non-targeted effects‏‎ (19:31, 26 February 2021)
  30. Normal tissue complication probability‏‎ (19:33, 26 February 2021)
  31. Pooled analysis‏‎ (19:34, 26 February 2021)
  32. Quasi-threshold dose‏‎ (19:35, 26 February 2021)
  33. Reactive oxygen species‏‎ (19:36, 26 February 2021)
  34. Recovery (cellular or tissue)‏‎ (19:38, 26 February 2021)
  35. Reference Animal and Plant‏‎ (19:43, 26 February 2021)
  36. Relative biological effectiveness‏‎ (20:22, 26 February 2021)
  37. Relative risk‏‎ (20:25, 26 February 2021)
  38. Risk coefficient‏‎ (20:30, 26 February 2021)
  39. Targeted effects‏‎ (20:32, 26 February 2021)
  40. Translocation‏‎ (20:33, 26 February 2021)
  41. Radiation source‏‎ (21:04, 26 February 2021)
  42. Dose-response function‏‎ (14:57, 28 March 2021)
  43. Tissue weighting factor‏‎ (21:32, 28 March 2021)
  44. Absorption‏‎ (22:15, 28 March 2021)
  45. Activation‏‎ (22:16, 28 March 2021)
  46. Activity‏‎ (22:19, 28 March 2021)
  47. ICRPædia Guide to the System of Radiological Protection‏‎ (21:44, 3 May 2021)
  48. Active detection system‏‎ (19:35, 11 August 2021)
  49. Additional dose‏‎ (19:36, 11 August 2021)
  50. Allometry‏‎ (19:37, 11 August 2021)

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)